SCHEMBL10657308

SCHEMBL10657308

CCCC(=O)C(O)n1cc(F)c(=O)[nH]c1=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 5/20 0.46
SQOR Q9Y6N5 2/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
MAPK3 P27361 1/20 0.43
ASAH1 Q13510 1/20 0.43
KDM4E B2RXH2 1/20 0.42
CYP1A2 P05177 1/20 0.42
GRIA1 P42261 1/20 0.42
GRIA2 P42262 1/20 0.42
GRIA3 P42263 1/20 0.42
GRIA4 P48058 1/20 0.42
GRIK5 Q16478 1/20 0.42
ALDH1A1 P00352 1/20 0.38
CYP2C19 P33261 1/20 0.38
KMT2A Q03164 1/20 0.37
TSHR P16473 1/20 0.35
MAPT P10636 1/20 0.35
PMP22 Q01453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10504851 0.79 ALDH1A1 (0.43) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL8200014 0.74 SMN1; SMN2 (0.53) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL28820836 0.74 SMN1; SMN2 (0.50) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL22144418 0.73 SMN1; SMN2 (0.56) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL11092234 0.73 LMNA (0.57) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL24235951 0.72 SMN1; SMN2 (0.58) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL1700856 0.71 SMN1; SMN2 (0.42) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL20058754 0.71 SMN1; SMN2 (0.57) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL10510362 0.71 SMN1; SMN2 (0.50) SMN1; SMN2LMNASQORCYP3A4CYP2D6
SCHEMBL28820770 0.70 LMNA (0.54) SMN1; SMN2LMNASQORCYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0265506-A1 A PRODRUG FORM OF 5-FLUOROURACIL AND A METHOD OF TREATMENT OF CANCER FARMACEUTISK LABORATORIUM FERRING A/S (DK) 1988-05-04 EP claimed
WO-1987006581-A1 A PRODRUG FORM OF 5-FLUOROURACIL AND A METHOD OF TREATMENT OF CANCER FARMACEUTISK LABORATORIUM FERRING A/S (DK) 1987-11-05 WO claimed
EP-0265506-A1 A PRODRUG FORM OF 5-FLUOROURACIL AND A METHOD OF TREATMENT OF CANCER FARMACEUTISK LABORATORIUM FERRING A/S (DK) 1988-05-04 EP disclosed
WO-1987006581-A1 A PRODRUG FORM OF 5-FLUOROURACIL AND A METHOD OF TREATMENT OF CANCER FARMACEUTISK LABORATORIUM FERRING A/S (DK) 1987-11-05 WO disclosed